18-F-Fluorodeoxyglucose-Positron Emission Tomography Evaluation of Early Metabolic Response During Radiation Therapy for Cervical Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1502-1507

  Schwarz, Julie K ^a   Lin, Lillie L ^b   Siegel, Barry A ^c,d   Miller, Tom R ^c,d   Grigsby, Perry W ^a,c,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

Brachytherapy; Cervix cancer; FDG PET; Radiation; Response

Indexed keywords

DIAGNOSTIC RADIOGRAPHY; DIFFUSERS (OPTICAL); IMAGE ENHANCEMENT; MEDICAL IMAGING; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; RADIATION; RADIOTHERAPY; TOMOGRAPHY; TUMORS;

BRACHYTHERAPY; CERVICAL CANCERS; CERVIX CANCER; COMPLETE RESPONSES; FDG PETS; FDG-PET; FLUORODEOXYGLUCOSE; METABOLIC ACTIVITIES; OPTIMAL TIMINGS; POSITRON EMISSIONS; PRETREATMENT; RADIATION THERAPIES; RESPONSE; STANDARDIZED UPTAKE VALUES; SYSTEMATIC STUDIES; TREATMENT PLANNING; TREATMENT RESPONSES; TUMOR RESPONSES;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; BRACHYTHERAPY; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; METABOLISM; MIDDLE AGED; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; REGRESSION ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 56349122461     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.03.040     Document Type: Article

References (37)

1. Xue F., Lin L.L., Dehdashti F., et al. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 101 (2006) 147-151
2. Kidd E.A., Siegel B.A., Dehdashti F., et al. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110 (2007) 1738-1744
3. Grigsby P.W., Siegel B.A., Dehdashti F., et al. Post-therapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 55 (2003) 907-913
4. 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome. J Clin Oncol 22 (2004) 2167-2171
5. Schwarz J.K., Siegel B.A., Dehdashti F., et al. Association of post-therapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298 (2007) 2289-2295
6. Schelling M., Avril N., Nahrig J., et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18 (2000) 1689-1695
7. Smith I.C., Welch A.E., Hutcheon A.W., et al. Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 18 (2000) 1676-1688
8. Weber W.A., Ott K., Becker K., et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19 (2001) 3058-3065
9. Ott K., Fink U., Becker K., et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial. J Clin Oncol 21 (2003) 4604-4610
10. Weber W.A., Petersen V., Schmidt B., et al. Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 21 (2003) 2651-2657
11. Kostakoglu L., Coleman M., Leonard J.P., et al. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 43 (2002) 1018-1027
12. Brun E., Kjellen E., Tennvall J., et al. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24 (2002) 127-135
13. Kong F.M., Frey K.A., Quint L.E., et al. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol 25 (2007) 3116-3123
14. Erdi Y.E., Macapinlac H., Rosenzweig K.E., et al. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 27 (2000) 861-866
15. Wieder H.A., Brucher B.L., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiation therapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22 (2004) 900-908
16. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47 (2006) 1241-1248
17. Hicks R.J., Mac Manus M.P., Matthews J.P., et al. Early FDG-PET imaging after radical radiation therapy for non-small-cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 60 (2004) 412-418
18. Lin L.L., Yang Z., Mutic S., et al. FDG-PET imaging for the assessment of physiologic volume response during radiation therapy in cervix cancer. Int J Radiat Oncol Biol Phys 65 (2006) 177-181
19. th ed. (2004), Lippincott Williams & Wilkins, Philadelphia, PA
20. Wright J.D., Gibb R.K., Geevarghese S., et al. Cervical carcinoma in the elderly. Cancer 103 (2005) 85-91
21. Miller T.R., and Grigsby P.W. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 353-359
22. Young H., Baum R., Cremerius U., et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35 (1999) 1773-1782
23. Kaplan E.L., and Meier P. Nonparametric statistics from incomplete observations. J. Am. Stat. Assoc 53 (1958) 901-913
24. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57 (1970) 579-594
25. Therasse P. Measuring the clinical response. What does it mean?. Eur J Cancer 38 (2002) 1817-1823
26. Spaepen K., Stroobants S., Dupont P., et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: Does [(18)F]FDG uptake correlate with the viable tumour cell fraction?. Eur J Nucl Med Mol Imaging 30 (2003) 682-688
27. Jacobs A.J., Faris C., Perez C.A., et al. Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosis. Cancer 57 (1986) 944-950
28. Hricak H. Cancer of the uterus: The value of MRI pre- and post-irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 1089-1094
29. Mayr N.A., Taoka T., Yuh W.T., et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 52 (2002) 14-22
30. Boss E.A., Massuger L.F., Pop L.A., et al. Post-radiation therapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma. J Magn Reson Imaging 13 (2001) 600-606
31. Hong J.H., Chen M.S., Lin F.J., et al. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 22 (1992) 913-917
32. Marcial V.A., and Bosch A. Radiation-induced tumor regression in carcinoma of the uterine cervix: Prognostic significance. Am J Roentgenol Radium Ther Nucl Med 108 (1970) 113-123
33. Grossman I., Kurohara S.S., Webster J.H., et al. The prognostic significance of tumor response during radiation therapy in cervical carcinoma. Radiology 107 (1973) 411-415
34. Lee C.M., Shrieve D.C., and Gaffney D.K. Rapid involution and mobility of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 58 (2004) 625-630
35. Mayr N.A., Magnotta V.A., Ehrhardt J.C., et al. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 35 (1996) 915-924
36. Mayr N.A., Yuh W.T., Taoka T., et al. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol 187 (2006) 65-72
37. Kidd E.A., El Naqa I.M., Deasy J.O., et al. FDG metabolic heterogeneity of cervical cancer. Int J Radiat Oncol Biol Phys 69 (2007) S115-S116